Here is an instance from my he bio-pharma work when N-of-8 listening and research produced significant results. A mid-sized biopharmaceutical company with a promising pipeline of new therapies exemplified this. Back in 2003, the drugs in research seemed to be in disparate categories: Crohn’s disease, MS, and Alzheimer’s disease. Then during N-of-8 groups, we asked a naïve question, “Is there any connection between them?” This childlike curiosity led us on an intriguing pursuit of a neuro-gastro commonality and we found an emerging appreciation of the brain-gut connection. By looking at the company’s existing research with a fresh perspective, we […]

NYU Langone Medical Center today announced its plan to launch a large-scale biotech “incubator” in Manhattan, which will begin hosting companies at the end of 2017. Named “BioLabs@NYULangone” and located at 180 Varick Street, the new center is designed to house up to 35 startup companies seeking to turn laboratory discoveries into profitable businesses in 50,000 square feet of fully equipped lab and office space. NYU Langone’s operations partner for the project is BioLabs, a leader in the management of shared laboratory centers nationwide. “The new center builds on the outstanding track record at NYU Langone in launching biomedical […]